{
    "nctId": "NCT03669926",
    "briefTitle": "The Tomosynthesis Trial in Bergen - Part 2",
    "officialTitle": "Digital Breast Tomosynthesis - The Future Screening Tool for Breast Cancer?",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 31082,
    "primaryOutcomeMeasure": "Compare rates of screen detected breast cancer after subsequent screening with DBT+SM after DBT+SM versus screening with DBT+SM after prior DM, as performed in a population based screening program.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written, informed consent to participation\n\nExclusion Criteria:\n\n* No written, informed consent to participation\n* Breast implants",
    "sex": "FEMALE",
    "minimumAge": "48 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}